Streetbeat News

Regulatory

CME

HOOD

MS

Major cryptocurrencies, including Bitcoin, Ethereum, and Dogecoin, are experiencing a dip despite a Senate vote to overturn a controversial SEC rule and significant inflows into Bitcoin ETFs. Notable developments include Morgan Stanley's $270M investment into Bitcoin ETFs and Robinhood's crypto trading volume slump.

Portfolio Pulse from Khyathi Dalal

May 16, 2024 | 8:48 pm

TCNNF

WBA

The DEA's decision to reschedule cannabis from Schedule I to Schedule III could significantly impact the cannabis industry, including tax changes, new regulations, and potential insurance coverage. Companies like Trulieve could see substantial financial benefits, while pharmacies like Walgreens may eventually dispense cannabis pending FDA approval.

Portfolio Pulse from Nicolás Jose Rodriguez

May 16, 2024 | 8:41 pm

ABAT

IE

TG

USAU

American Battery Technology ramps up its Nevada facility, U.S. Gold receives a permit for the CK Gold project, Tredegar's sale of Terphane is under review, and Ivanhoe Electric commits to a Native American initiative.

Portfolio Pulse from Austin DeNoce

May 16, 2024 | 8:39 pm

HLTH

Cue Health has announced a voluntary and temporary pause in the sales and distribution of its EUA Covid-19 test cartridge. The company is actively working with the FDA to resolve the issues raised and is collaborating with customers to find appropriate resolutions.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 8:26 pm

SPY

Federal Reserve's Raphael Bostic indicated that a continued decline in inflation could justify a rate reduction later this year, though he emphasized the need to remain open to various scenarios.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 8:16 pm

SPY

Federal Reserve's Raphael Bostic highlighted that lower shelter inflation is a significant development but cautioned that one data point does not make a trend. He emphasized the Fed's resolute and vigilant stance on inflation, noting continued pricing pressures in the economy.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 8:12 pm

AXNX

Axonics has received approval from the Therapeutic Goods Administration (TGA) to market its Axonics F15 product in Australia. This approval is a significant milestone for the company as it expands its market reach.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 8:08 pm

SPY

Atlanta Fed President Raphael Bostic expressed satisfaction with the progress on inflation in April but indicated that the Federal Reserve has not yet achieved its goals. This suggests that the Fed may continue its current monetary policy stance.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 8:06 pm

NUVL

Nuvalent's NVL-655 has received FDA Breakthrough Therapy Designation, which is a significant milestone for the company.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 8:02 pm

IVA

Inventiva received a positive recommendation from the Data Monitoring Committee to continue its Phase III clinical trial of lanifibranor for MASH/NASH without any protocol modifications. The decision was based on a review of safety data from over 900 patients, confirming the good safety profile of lanifibranor.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 8:02 pm